Analyst Ratings for Zenas Biopharma (ZBIO)
ZBIO Rating Summary
ZBIO Price Target Summary
- Highest: $55.00 (Guggenheim)
- Lowest: $32.00 (Morgan Stanley)
- Average: $44.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.00 (+37.6%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$44.00 (+37.6%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Morgan Stanley » Updated 8/17/2026 |
Judah C. Frommer | Downgrade | Equalweight (Overweight) |
32.00 (22.00) |
34.50 (31.98) |
-7.3% | Details |
| 3/20/2025 | Wedbush | Martin Fan | New Coverage | Outperform (N/A) |
35.00 (N/A) |
8.25 (31.98) |
287.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
